1 Outcomes of renal dysfunction in patients with acute liver failure.

2 Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study.

3 Alcohol-related liver diseases.

4 Impact of Size and Shape of Equine Femoral Subchondral Bone Cysts with a Transcondylar Screw On Predicted Bone Formation Area in a Finite Element Model.

5 Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation.

6 Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.

7 transcriptome analysis of acute phase liver graft injury in liver transplantation

8 analysis of risk factors for recurrence and metastasis in patients with hepatocellular carcinoma after liver transplantation

9 survival benefits of interferon-based therapy in patients with recurrent hepatitis c after orthotopic liver transplantation

10 prospective study on the effect of omega-3 fish oil emulsion on inflammatory responses, immune function, and prognosis in patients with liver transplantation

11 anesthetic considerations in parturients with liver transplant

12 the validity of central venous to arterial carbon dioxide difference to predict adequate fluid management during living donor liver transplantation. a prospective observational study

13 o vivencial dos enfermeiros no programa de transplante de fígado de um hospital público la vivencia de los enfermeros en el programa de transplante de hígado de un hospital público nursing perceptions in the liver transplant program of a public hospital in brazil

14 an update on endoscopic management of post-liver transplant biliary complications

15 characteristic changes and their significance of peripheral follicular helper t cell subsets in liver transplant patient

16 liver transplantation in hiv-positive patients: the position of the brazilian groups transplante hepático em pacientes hiv-positivo: a posição dos grupos brasileiros

17 resultado do inquérito nacional sobre condutas no acompanhamento e no tratamento da recurrência da hepatite c em portadores de vírus c submetidos a transplante de fígado national survey about management and treatment options of hepatitis c recurrence after liver transplantation

18 intensive care of patient with two-stage liver transplantation- case report

19 cytomegalovirus-associated immune thrombocytopenic purpura after liver transplantation

20 vanishing tumor in a liver graft from a hepatitis b virus surface antigen-positive donor

21 hepatic epithelioid hemangioendothelioma in taiwan: a clinicopathologic study of six cases in a single institution over a 15-year period

22 prognosis of hepatocellular carcinoma after liver transplantation: comparative analysis with partial hepatectomy

23 trasplante hepático, técnica de anastomosis biliar y complicaciones en una década de trabajo

24 emerging importance of autoimmune hepatitis in children in taiwan, an endemic area for viral hepatitis

25 orthotopic liver transplantation from cardiac death donors in the mouse: a new model and evaluation of cardiac death time

26 Exercise training is safe and feasible in patients awaiting liver transplantation: a pilot randomized controlled trial.

27 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

28 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

29 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

30 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

31 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

32 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

33 Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt

34 Dermatological Disorders following Liver Transplantation: An Update

35 Echinocandins for management of invasive candidiasis in patients with liver disease and liver transplantation

36 Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria

37 Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt

38 Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series

39 Roles of Epstein–Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation

40 [Lipid spectrum and function of kidneys before and after liver transplantation].

41 Probable sirolimus-induced rupture of arterial anastomosis after liver transplantation in a patient intolerant of tacrolimus

42 Corrigendum to “Successful percutaneous treatment of biliary stenosis after living donor liver transplantation in a child” [Radiol Case Rep 14 (2019) 800–804](S1930043319301530)(10.1016/j.radcr.2019.03.039)

43 Percutaneous transhepatic stenting in management of post living donor liver transplantation hepatic venous stenosis

44 Liver transplantation as a rescue surgery after failure of embolization of a giant hepatic artery pseudoaneurysm.

45 Risk factors for the metabolic syndrome components of hypertension, diabetes mellitus, and dyslipidemia after living donor liver transplantation.

46 Infectious complications in pediatric liver transplantation candidates.

47 Liver transplantation for acute liver failure due to toxic agent ingestion in children.

48 Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time

49 Portal vein variation and thrombosis in right lobe living donor liver transplantation

50 Effects of thiopental in cold ischemia in liver transplantation: An experimental study

51 Perioperative characteristics and management of liver transplantation for isolated methylmalonic acidemia-the largest experience in China.

52 Patient perspectives of weight gain following orthotopic liver transplantation: a qualitative study.

53 Splenectomy is not indicated in living donor liver transplantation.

54 How safe is pregnancy after liver transplantation? A large case series study at tertiary referral center in Turkey

55 The impact of the COVID-19 outbreak on Liver Transplantation programmes in Northern Italy.

56 Biliary Reconstruction in Adult Live Donor Liver Transplantation - "The All Knots Outside Technique"

57 the potential role of liver transplantation as a treatment option in colorectal liver metastases

58 endoscopic management of biliary complications following liver transplantation after donation from cardiac death donors

59 perioperative monitoring of intracranial pressure using optic nerve sheath diameter in paediatric liver transplantation

60 safety and efficacy of small bowel examination by capsule endoscopy for patients before liver transplantation

61 propofol activation of the nrf2 pathway is associated with amelioration of acute lung injury in a rat liver transplantation model

62 the natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation – a single-centre experience

63 gene silencing of 4-1bb by rna interference inhibits acute rejection in rats with liver transplantation

64 orthotropic liver transplantation for intractable neurological manifestations of wilson′s disease

65 outcomes following liver transplantation for patients with alcohol- versus nonalcohol-induced liver disease

66 recommendations of long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the american association for the study of liver diseases and the american society of transplantation

67 dyskeratosis congenita induced cirrhosis for liver transplantation-perioperative management

68 salvage with a secondary infrahepatic cavocavostomy of the occluded modified piggyback anastomosis during split liver transplantation: a case report

69 pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis c after liver transplantation: from a canadian experience to recommendations for therapy

70 contracepção e gravidez após transplante hepático: uma visão atual contraception and pregnancy after liver transplantation: an update overview

71 blood transfusion practices in liver transplantation

72 oral cavity metastasis of hepatocellular carcinoma following liver transplantation

73 factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study

74 the impact of sirolimus on hepatitis c recurrence after liver transplantation

75 aortic balloon valvuloplasty prior to orthotopic liver transplantation: a novel approach to aortic stenosis and end-stage liver disease

76 immune response following liver transplantation compared to kidney transplantation: usefulness of monitoring peripheral blood cd4+ adenosine triphosphate activity and cytochrome p450 3a5 genotype assay

77 the population pharmacokinetic models of tacrolimus in chinese adult liver transplantation patients

78 neuroendocrine liver metastases and orthotopic liver transplantation: the us experience

79 perioperative use of allogenic blood components in live-related donor orthotopic liver transplantation: a cross sectional study

80 bypass during liver transplantation: anachronism or revival? liver transplantation using a combined venovenous/portal venous bypass—experiences with 163 liver transplants in a newly established liver transplantation program

81 use of elderly donors (> 60 years) for liver transplantation

82 serum aspartate aminotransferase level and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis c

83 abo incompatible liver transplantation as a bridge to treat hellp syndrome

84 coma hiperosmolar associado ao transplante de fígado hyperosmolar coma associated with liver transplantation

85 treatment of hepatic artery thrombosis after orthotopic liver transplantation

86 survival after liver transplantation for hepatitis c is unchanged over two decades in canada

87 comparison of the warmcloud and bair hugger warming devices for the prevention of intraoperative hypothermia in patients undergoing orthotopic liver transplantation: a randomized clinical trial

88 propylthiouracil-induced acute liver failure: role of liver transplantation

89 molecular signatures of recurrent hepatocellular carcinoma secondary to hepatitis c virus following liver transplantation

90 Alopecia in Children Following Living Related Liver Transplantation.

91 Impact of Pretransplant Bridging Locoregional Therapy for Patients with Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients from the US Multicenter HCC Transplant Consortium

Keyword Connections

Journals

Research Groups

Bibliographies